Discontinuation report MYLAN-RISPERIDONE ODT
Report ID | 149759 |
Drug Identification Number | 02413485 |
Brand name | MYLAN-RISPERIDONE ODT |
Common or Proper name | Risperidone |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-11-15 |
Remaining supply date | 2021-11-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 3360. Last lot 3075665-1 exp 2018-10-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-11-23 | French | Compare |
v1 | 2021-11-23 | English | Compare |
Showing 1 to 2 of 2